Literature DB >> 15948044

Solid-state fluorescence studies of some polymorphs of diflunisal*.

Harry G Brittain1, Bruce J Elder, Paul K Isbester, Allen H Salerno.   

Abstract

PURPOSE: The solid-state luminescence spectroscopy of organic molecules is strongly affected by the effects of excited state energy transfer, with the fluorescence of solids often differing significantly from the fluorescence of the molecule dissolved in a solution phase. Because the magnitude of these solid-state effects is determined by the crystallography of the system, solid-state fluorescence studies can be used to gain insight into the polymorphism of the system. To this end, the spectroscopic properties of four polymorphs of diflunisal have been obtained, and compared to the properties of the molecule in the solution phase.
METHODS: Fluorescence excitation and emission spectra were obtained on four polymorphic forms of diflunisal, and on the compound dissolved in water.
RESULTS: It was found that exciton effects dominate the excitation spectra of diflunisal in the four studied polymorphic forms. These phenomena lead to a decrease in the energy of the excitation bands relative to that observed for the free molecule in fluid solution, and in a splitting of the excitation peak into two Davydov components.
CONCLUSIONS: The trends in the excitation and emission spectra led to the grouping of diflunisal Forms I, II, and III into one category, and diflunisal Form IV into a separate category. Because other work has established that Form IV is characterized by the highest crystal density and consequent degree of intermolecular interaction, the magnitude of the exciton coupling can be used to estimate the degree of face-to-face overlap of the salicylate-type fluorophores.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948044     DOI: 10.1007/s11095-005-4595-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Red, orange and yellow crystals of 4,5-bis(4-methoxyphenyl)-2-(3-nitrophenyl)-1H-imidazole

Authors: 
Journal:  Acta Crystallogr C       Date:  2000-07       Impact factor: 1.172

2.  Interrelation between thermochemical and structural data of polymorphs exemplified by diflunisal.

Authors:  German L Perlovich; Lars Kr Hansen; Annette Bauer-Brandl
Journal:  J Pharm Sci       Date:  2002-04       Impact factor: 3.534

Review 3.  Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.

Authors:  Patrick A Tishmack; David E Bugay; Stephen R Byrn
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

4.  Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms.

Authors:  W P Findlay; D E Bugay
Journal:  J Pharm Biomed Anal       Date:  1998-02       Impact factor: 3.935

Review 5.  Spectral methods for the characterization of polymorphs and solvates.

Authors:  H G Brittain
Journal:  J Pharm Sci       Date:  1997-04       Impact factor: 3.534

Review 6.  Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.

Authors:  D E Bugay
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

7.  Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.

Authors:  M C Martínez-Ohárriz; C Martín; M M Goñi; C Rodríguez-Espinosa; M C Tros de Ilarduya-Apaolaza; M Sánchez
Journal:  J Pharm Sci       Date:  1994-02       Impact factor: 3.534

8.  Conformational color polymorphism and control of crystallization of 5-methyl-2-[(4-methyl-2-nitrophenyl)amino]-3-thiophenecarbonitrile.

Authors:  X He; U J Griesser; J G Stowell; T B Borchardt; S R Byrn
Journal:  J Pharm Sci       Date:  2001-03       Impact factor: 3.534

9.  Fluorescence studies of the transformation of carbamazepine anhydrate form III to its dihydrate phase.

Authors:  Harry G Brittain
Journal:  J Pharm Sci       Date:  2004-02       Impact factor: 3.534

  9 in total
  3 in total

1.  Solid-state fluorescence of the trihydrate phases of ampicillin and amoxicillin.

Authors:  Harry G Brittain
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

2.  Preparation, Characterization, Solubility, and Antioxidant Capacity of Ellagic Acid-Urea Complex.

Authors:  Hitomi Sakurai; Mitsuaki Suzuki; Shoko Itakura; Hiroaki Todo; Florencio Arce; Gerard Lee See; Takashi Tanikawa; Yutaka Inoue
Journal:  Materials (Basel)       Date:  2022-04-12       Impact factor: 3.748

3.  Concurrent Local Delivery of Diflunisal Limits Bone Destruction but Fails To Improve Systemic Vancomycin Efficacy during Staphylococcus aureus Osteomyelitis.

Authors:  Thomas J Spoonmore; Caleb A Ford; Jacob M Curry; Scott A Guelcher; James E Cassat
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.